Kauser M. Akhoon

Array ( [id] => 9245426 [patent_doc_number] => 08609707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Formulations of bendamustine' [patent_app_type] => utility [patent_app_number] => 13/016473 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5780 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13016473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721317 [patent_doc_number] => 20130072534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'COMPOSITIONS COMPRISING VENLAFAXINE AND CELECOXIB IN THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 13/517264 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6520 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566142 [patent_doc_number] => 20120328713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Articles of Manufacture with Improved Anti-microbial Properties' [patent_app_type] => utility [patent_app_number] => 13/515633 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13348 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649661 [patent_doc_number] => 20130035391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'Felbinac-Containing Transdermally Absorbable Preparation' [patent_app_type] => utility [patent_app_number] => 13/516008 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4875 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452716 [patent_doc_number] => 20120263659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'USE OF PHYSIOLOGICAL COOLING ACTIVE INGREDIENTS, AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/510454 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 56675 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9995502 [patent_doc_number] => 09040095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'Colon cleansing of residual stool and secretions during colonoscopy' [patent_app_type] => utility [patent_app_number] => 13/502344 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10196 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11683999 [patent_doc_number] => 09682031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Microcapsules comprising benzoyl peroxide and topical compositions comprising them' [patent_app_type] => utility [patent_app_number] => 13/500423 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 47 [patent_no_of_words] => 13197 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344462 [patent_doc_number] => 08663608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Hydroxytyrosol compounds' [patent_app_type] => utility [patent_app_number] => 13/497483 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 6362 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8041539 [patent_doc_number] => 20120070503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation' [patent_app_type] => utility [patent_app_number] => 12/886334 [patent_app_country] => US [patent_app_date] => 2010-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4006 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070503.pdf [firstpage_image] =>[orig_patent_app_number] => 12886334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301064 [patent_doc_number] => 20120183627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF HEMORRHOIDS AND RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/393480 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5312 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264786 [patent_doc_number] => 20120164217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'SCENTED CAPSULES' [patent_app_type] => utility [patent_app_number] => 13/394034 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4791 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228501 [patent_doc_number] => 20120142704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'PHARMACEUTICAL SOLUTION OF CETIRIZINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 13/389775 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12059 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184070 [patent_doc_number] => 20120114632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'STABILIZED ACTIVE HALOGEN SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/384923 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4565 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114632.pdf [firstpage_image] =>[orig_patent_app_number] => 13384923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173633 [patent_doc_number] => 20120108546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'SYNERGISTIC ANTIMICROBIAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/382407 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1948 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108546.pdf [firstpage_image] =>[orig_patent_app_number] => 13382407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018482 [patent_doc_number] => 09060949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Menthyl carbamate compounds as skin and/or hair lightening actives' [patent_app_type] => utility [patent_app_number] => 13/699543 [patent_app_country] => US [patent_app_date] => 2010-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28845 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199650 [patent_doc_number] => 20120122976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'PHOSPHATE-FREE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/320459 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6372 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122976.pdf [firstpage_image] =>[orig_patent_app_number] => 13320459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817560 [patent_doc_number] => 20120064180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'USE OF NO AND NO DONORS FOR TERMINATING DORMANCY IN INVERTEBRATES' [patent_app_type] => utility [patent_app_number] => 13/320300 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13279 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064180.pdf [firstpage_image] =>[orig_patent_app_number] => 13320300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817510 [patent_doc_number] => 20120064130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'METHOD FOR IMPREGNATION WITH SUPERCRITICAL CO2' [patent_app_type] => utility [patent_app_number] => 13/320453 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7020 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064130.pdf [firstpage_image] =>[orig_patent_app_number] => 13320453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160456 [patent_doc_number] => 20120101159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'IBUPROFEN LYSINATE ORAL SUSPENSION' [patent_app_type] => utility [patent_app_number] => 13/266730 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2048 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101159.pdf [firstpage_image] =>[orig_patent_app_number] => 13266730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568774 [patent_doc_number] => 20100273203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING METABOLITES' [patent_app_type] => utility [patent_app_number] => 12/766635 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26277 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273203.pdf [firstpage_image] =>[orig_patent_app_number] => 12766635 [rel_patent_id] =>[rel_patent_doc_number] =>)